Hypertension Treatment in Diabetes: Focus on Heart Failure Prevention

Area of Science:

• Cardiology
• Endocrinology
• Pharmacology

Background:

• Diabetes mellitus significantly increases the risk of cardiovascular disease (CVD) and adverse cardiovascular outcomes.
• Hypertension management is a cornerstone in reducing cardiovascular events among individuals with diabetes.
• Existing guidelines recommend specific antihypertensive classes for diabetic patients, particularly those with microalbuminuria.

Purpose of the Study:

• To review the role of antihypertensive management in patients with diabetes.
• To highlight the benefits of specific drug classes, including angiotensin-converting enzyme inhibitors, aldosterone receptor blockers, calcium channel blockers, and diuretics.
• To introduce the emerging role of sodium glucose transporter 2 inhibitors in blood pressure control and cardiovascular risk reduction in diabetes.

Main Methods:

• Literature review of studies on antihypertensive therapies in diabetic populations.
• Analysis of American Diabetes Association recommendations.
• Evaluation of recent findings on sodium glucose transporter 2 inhibitors.

Main Results:

• Angiotensin-converting enzyme inhibitors or aldosterone receptor blockers are recommended as first-line treatments, often followed by calcium channel blockers or diuretics.
• Sodium glucose transporter 2 inhibitors have demonstrated efficacy in improving blood pressure control.
• Emerging evidence suggests sodium glucose transporter 2 inhibitors contribute to cardiovascular risk reduction in diabetic patients.

Conclusions:

• Comprehensive management of hypertension is essential for improving cardiovascular outcomes in diabetes.
• Current treatment strategies involve sequential use of established antihypertensive classes.
• Sodium glucose transporter 2 inhibitors represent a promising therapeutic option for concurrent blood pressure management and cardiovascular protection in patients with diabetes.